...
首页> 外文期刊>Annals of Clinical Microbiology and Antimicrobials >Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis
【24h】

Synthetic arylquinuclidine derivatives exhibit antifungal activity against Candida albicans, Candida tropicalis and Candida parapsilopsis

机译:合成的芳基奎尼丁衍生物对白色念珠菌,热带念珠菌和副念珠菌具有抗真菌活性

获取原文
           

摘要

Background Sterol biosynthesis is an essential pathway for fungal survival, and is the biochemical target of many antifungal agents. The antifungal drugs most widely used to treated fungal infections are compounds that inhibit cytochrome P450-dependent C14α-demethylase (CYP51), but other enzymes of this pathway, such as squalene synthase (SQS) which catalyses the first committed step in sterol biosynthesis, could be viable targets. The aim of this study was to evaluate the antifungal activity of SQS inhibitors on Candida albicans, Candida tropicalis and Candida parapsilopsis strains. Methods Ten arylquinuclidines that act as SQS inhibitors were tested as antiproliferative agents against three ATCC strains and 54 clinical isolates of Candida albicans, Candida tropicalis and Candida parapsilopsis. Also, the morphological alterations induced in the yeasts by the experimental compounds were evaluated by fluorescence and transmission electron microscopy. Results The most potent arylquinuclidine derivative (3-[1'-{4'-(benzyloxy)-phenyl}]-quinuclidine-2-ene) (WSP1267) had a MIC50 of 2 μg/ml for all species tested and MIC90 varying from 4 μg/ml to 8 μg/ml. Ultrathin sections of C. albicans treated with 1 μg/ml of WSP1267 showed several ultrastructural alterations, including (a) loss of cell wall integrity, (b) detachment of the plasma membrane from the fungal cell wall, (c) accumulation of small vesicles in the periplasmic region, (d) presence of large electron-dense vacuoles and (e) significantly increased cell size and cell wall thickness. In addition, fluorescence microscopy of cells labelled with Nile Red showed an accumulation of lipid droplets in the cytoplasm of treated yeasts. Nuclear staining with DAPI revealed the appearance of uncommon yeast buds without a nucleus or with two nuclei. Conclusion Taken together, our data demonstrate that arylquinuclidine derivatives could be useful as lead compounds for the rational synthesis of new antifungal drugs.
机译:背景甾醇的生物合成是真菌存活的重要途径,并且是许多抗真菌剂的生化靶标。最广泛用于治疗真菌感染的抗真菌药物是抑制细胞色素P450依赖性C14α-脱甲基酶(CYP51)的化合物,但是该途径的其他酶,例如角鲨烯合酶(SQS),可以催化固醇生物合成中第一个重要步骤。成为可行的目标。这项研究的目的是评估SQS抑制剂对白色念珠菌,热带念珠菌和副念珠菌菌株的抗真菌活性。方法测试了十种作为SQS抑制剂的芳基奎尼丁作为抗增殖药,针对三株ATCC菌株和54株白色念珠菌,热带念珠菌和副产念珠菌临床分离株。同样,通过荧光和透射电子显微镜评价了由实验化合物在酵母中诱导的形态学改变。结果最有效的芳基奎宁环衍生物(3- [1'-{4'-(苄氧基)-苯基}]-奎宁环-2-烯)(WSP1267)的MIC 50 为2μg/ ml所有受测物种的MIC 90 从4μg/ ml变到8μg/ ml。用1μg/ ml WSP1267处理的白色念珠菌超薄切片显示了几种超微结构改变,包括(a)细胞壁完整性丧失,(b)质膜从真菌细胞壁上脱落,(c)小囊泡积聚在周质区域中,(d)存在大的电子致密液泡和(e)显着增加细胞大小和细胞壁厚度。另外,用尼罗红标记的细胞的荧光显微镜显示在处理过的酵母的细胞质中脂质滴的积累。用DAPI进行核染色可显示出不常见的无核或有两个核的酵母芽。结论综上所述,我们的数据表明,芳基奎宁环衍生物可作为先导化合物合理合成新的抗真菌药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号